StockData

Medinotec Inc. (MDNC) stock

MDNCOTCSurgical & Medical Instruments & ApparatusFiscal year ends February 28
Financials through Q2 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026Score 9/30
$5.00+0.00 (0.00%)

Close on Oct 16, 2026Market cap $58.78MP/E –Yield –

Medinotec gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Medinotec's gross profit for the twelve months ending Aug 31, 2026 was $5.07M, down 19.3% year over year. For fiscal 2026 it was $5.13M, up 6.4% from the year before.

Annual gross profit

PeriodPeriod endValueChange
FY2026Feb 28, 2026$5.13M+6.4%
FY2025Feb 28, 2025$4.82M+97.3%
FY2024Feb 29, 2024$2.44M+319.8%
FY2023Feb 28, 2023$581.82K–

Quarterly gross profit

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2027CQ3 2026Aug 31, 2026$1.56M-21.3%
Q1 FY2027CQ2 2026May 31, 2026$1.31M+43.2%
Q4 FY2026CQ1 2026Feb 28, 2026$854.56K-63.5%
Q3 FY2026CQ4 2025Nov 30, 2025$1.35M+29.3%
Q2 FY2026CQ3 2025Aug 31, 2025$1.98M+138.0%
Q1 FY2026CQ2 2025May 31, 2025$913.17K+52.1%
Q4 FY2025CQ1 2025Feb 28, 2025$2.34M+141.4%
Q3 FY2025CQ4 2024Nov 30, 2024$1.04M+20.5%
Q2 FY2025CQ3 2024Aug 31, 2024$833.41K+187.6%
Q1 FY2025CQ2 2024May 31, 2024$600.28K+88.9%
Q4 FY2024CQ1 2024Feb 29, 2024$971.04K+500.8%
Q3 FY2024CQ4 2023Nov 30, 2023$863.92K+286.9%
Q2 FY2024CQ3 2023Aug 31, 2023$289.80K+235.3%
Q1 FY2024CQ2 2023May 31, 2023$317.71K+187.7%
Q4 FY2023CQ1 2023Feb 28, 2023$161.63K–
Q3 FY2023CQ4 2022Nov 30, 2022$223.30K–
Q2 FY2023CQ3 2022Aug 31, 2022$86.44K–
Q1 FY2023CQ2 2022May 31, 2022$110.45K–

More Medinotec figures

See a number that looks wrong?